US Patent 7723290 Compositions and methods for modulating the immune system
Patent 7723290 was granted and assigned to Bioincept on May, 2010 by the United States Patent and Trademark Office.
All edits
A novel class of embryo derived peptides are described (Preimplantation factor) that were generated synthetically and were tested on peripheral blood immune cells and shown to block activated but not basal immunity, inhibiting cell proliferation and creating a TH2 type cytokine bias, in addition PIF enhance endometrial receptivity by increasing adhesion molecules expression. PIF biological activity appears to be exerted by specific binding to inducible receptors present on the several white cell lineages. PIF peptides, which are immune modulators therefore may have diagnostic non toxic therapeutic applications in improving fertility, reducing pregnancy loss as well may be useful when administered for the treatment of autoimmune diseases and for prevention xenotransplants rejection.
US Patent 07723290 Compositions and methods for modulating the immune system US Patent 7723290 Compositions and methods for modulating the immune system
US Patent 07723290 Compositions and methods for modulating the immune system
Find more entities like US Patent 7723290 Compositions and methods for modulating the immune system
